Cypre Inc. Email Format
Biotechnology ResearchUnited States2-10 Employees
Cypre is a biotechnology company developing tumor organoid platforms to enable more predictive oncology. Our 3D organoids incorporate tumor, stromal, and immune components in high-throughput formats, built to replace animal models and better capture complex mechanisms of action (MOA). Cypre’s platform supports immunotherapy development through functional insight, MOA analytics, and emerging biomarker discovery — accelerating the path toward precision medicine.